Compare Vertiv Holdings Co (VRT) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertiv Holdings Co vs 22nd Century Group Inc — how do they compare? Vertiv Holdings Co trades at $244.22 (market cap $93.83B), while 22nd Century Group Inc trades at $0.84 (market cap $621.67K). The key difference: Vertiv Holdings Co is far larger — about 150932.2× 22nd Century Group Inc's market cap, and Vertiv Holdings Co pays a 0.1% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vertiv Holdings Co for 39 Days and 22nd Century Group Inc for 32 Days on average.
| VRT | XXII | |
|---|---|---|
Market Cap | $93.83B | $621.67K |
Volume | 5,855,911 | 45,625 |
Sector | Industrials | Consumer Staples |
52-Week High | $376.23 | $483.00 |
52-Week Low | $149.83 | $0.80 |
Typical Hold Time | 39 Days | 32 Days |
Enterprise Value | $94.06B | -$3.69M |
Dividend Yield | 0.1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vertiv Holdings (VRT) trades at $244.94, down 0.63% for the day, as technical indicators signal bearish momentum with the stock below key resistance levels. The company demonstrates strong fundamental performance with Q2 2026 EPS of $1.52 beating estimates of $1.42, continuing a pattern of earnings surprises. Revenue growth remains robust at $11.5B projected for 2026, while profitability metrics show improvement with net income margin expanding to 15.09%. Recent news highlights VRT's strategic positioning in AI data center infrastructure, though legal investigations following a stock drop present near-term concerns.
The investment outlook remains positive based on strong analyst consensus with 95% buy ratings and a $364.94 price target representing 49% upside potential. Key opportunities include VRT's leadership in data center cooling solutions amid AI infrastructure growth, while risks involve potential securities law violations investigation and competitive pressures in the industrial technology sector. The company's cash flow generation remains healthy with $1.2B net cash flow projected for 2026, supporting continued business expansion.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
